Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparative gene expression profile of chronic myeloid leukemia cells innately resistant to imatinib mesylate

24 Oct 2003

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Myeloid Leukemia Treatments
Share to Eosinophilic Disorders and Syndromes

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 14585372
DOI: 10.1016/j.exphem.2003.08.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparative gene expression profile of chronic myeloid leukemia cells innately resistant to imatinib mesylatePMID 14585372Read ↗

Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patientsSemantic proximity Read ↗

A gene expression profile associated with relapse of cytogenetically normal acute myeloid leukemia is enriched for leukemia stem cell genesSemantic proximity Read ↗

A Single-Cell Atlas Identifies Pretreatment Features of Primary Imatinib Resistance in Chronic Myeloid LeukemiaSemantic proximity Read ↗

A Single-cell Atlas Identifies Pretreatment Features of Primary Imatinib Resistance in Chronic Myeloid LeukemiaSemantic proximity Read ↗

Phenotypic and functional characterization of subpopulation of Imatinib resistant chronic myeloid leukemia cell line.Semantic proximity Read ↗

Imatinib therapy of chronic myeloid leukemia restores the expression levels of key genes for DNA damage and cell-cycle progressionSemantic proximity Read ↗

The role of microRNAs in the development, progression and drug resistance of chronic myeloid leukemia and their potential clinical significanceSemantic proximity Read ↗

The Biology of Chronic Myelogenous Leukemia: Implications for Imatinib TherapySemantic proximity Read ↗

Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (CML)Semantic proximity Read ↗

Microarray-based gene expression profiling of hematologic malignancies: basic concepts and clinical applicationsSemantic proximity Read ↗

Differentially expressed genes responsible for insensitivity of CD34+ cells to kinase inhibitors in patients with chronic myeloid leukemiaSemantic proximity Read ↗

Comprehensive analysis of tyrosine kinase domain mutations and imatinib resistance in chronic myeloid leukemia patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.